Talphera, Inc. (TLPH)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $1.06
- As of
Kresmion compiles this page from TLPH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
TALPHERA, INC. (TLPH): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-12.
See the full TLPH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TLPH on one page. Preview it with sample data, then open it live with a free account.
Preview the TLPH dossierActive signals for TLPH
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 52% of TLPH (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 11.8%, EPS $-0.06 vs $-0.068 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 23.0% - EPS $-0.11 vs $-0.1428 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 26.5% - EPS $-0.06 vs $-0.0816 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 44.0% - EPS $-0.04 vs $-0.0714 estimate
FREE, NO ACCOUNT
Every signal on TLPH, as it fires
New filings, 13F moves and cross asset signals on TLPH land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TLPH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 00444T209 · 2026Q2 | $117K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TLPH
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
TLPH against its peers
TLPH's operating margin of -48157.1% ranks in the 3rd percentile of 15 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | TLPH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 28000 USD | 37.9M USD | 8 | 17 |
| Gross margin | n/a | 38.6% | n/a | 15 |
| Operating margin | -48157.1% | -7.3% | 3 | 15 |
| Net margin | -51035.7% | -26.1% | 3 | 17 |
| Return on equity | -83.9% | -15.9% | 17 | 14 |
| 1 year | -7.0% | -43.0% | 70 | 14 |
Peers (20): LEEEF, SCYX, CWBHF, IXHL, ZYBT, PLNH, JUSHF, AAWH, ITHUF, RMTI, INIS, CXXIF, GRUSF, CPIX, RAPH, CPHI, MRMD, ETST, SHPH, BGM. Left out: GSTK (no annual filing), INCR (period gap), CTOR (no annual filing), HSTI (period gap), CPIVF (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (TLPH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow TLPH on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to TLPH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.